SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending as the company tests driverless cars in Austin, leading to speculation about full autonomy and future robotaxi services. The community is actively discussing the implications of this technology and potential impact on Tesla's valuation, with some pointing to high P/E ratios. Bullish sentiment is fueled by the possibility of new highs and a 'Santa Claus rally,' while bears express concerns about overvaluation and market manipulation.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is trending as traders assess its recent price drop amid concerns about AI infrastructure spending and potential rate hikes. Community discussions range from short-term bearish sentiment and technical analysis to long-term bullish outlooks based on the company's fundamentals and contracted revenue. Investors are weighing the impact of potential AI bubble concerns against IREN's growth prospects and existing deals.

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is trending as traders assess recent market weakness and look ahead to key economic data releases, like the jobs report, that could influence future Federal Reserve policy. Community discussions revolve around whether the current pullback is a buying opportunity or a sign of further declines, with some focusing on overnight trading and potential market manipulation. Concerns about AI stocks and the impact of a potential Yen carry trade are also contributing to the conversation.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

RKLB is trending due to a mix of factors including a recently aborted launch, planned share sales by Peter Beck, and broader tech sector volatility, leading to community discussion about short-term turbulence versus long-term potential. Despite these headwinds, many investors express confidence in the company's fundamentals and future growth, particularly related to the Neutron rocket and potential government contracts. The stock's movement is also influenced by speculation around a potential SpaceX IPO and its impact on the space sector.

AMC Robotics Corp. engages in developing and deploying AI-enabled robotics and smart security solutions, especially for warehouse automation, enterprise security, robotics patrol/incident-response and logistics automation. The company is headquartered in New York, NY.

AMC Robotics Corp.

AMCI is trending due to its explosive move and after-hours continuation, with community members actively discussing potential price targets and the possibility of a short squeeze. The stock, a robotics de-SPAC, is garnering attention despite sector challenges, with some drawing parallels to previous high-flying stocks and anticipating further gains. Traders are closely monitoring key resistance levels and potential breakout points.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending amid concerns about potential market crashes and reactions to upcoming economic data, like the jobs report, creating uncertainty. Community discussions revolve around the possibility of a Santa rally versus deeper market corrections, with some traders expressing frustration over perceived market manipulation. Broader economic fears, including concerns about debt markets and potential impact from international monetary policy, are also contributing to the cautious sentiment.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

After a significant dip attributed to broader AI sector concerns and potential overreactions to $ORCL news, $CRWV is seeing active debate about its oversold condition and potential for a rebound. The community is closely watching for a recovery, fueled by its strong backlog and Nvidia's involvement, while also considering factors like insider selling and convertible debt. Discussions range from potential short squeezes to long-term bullish perspectives on AI infrastructure.

Radiopharm Theranostics Ltd. operates as a pre-clinical and clinical research company. It focuses on the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical need. The company is founded by Paul A. Hopper in 2021 headquartered Carlton, Australia.

Radiopharm Theranostics Ltd - ADR

RADX is trending due to significant intraday volatility following positive interim data from its RAD 101 trial, with community members actively discussing short squeeze potential and upcoming webinar catalysts. The stock experienced a massive volume spike and a large price surge, leading to considerable debate on potential price targets and the possibility of a short squeeze. Despite some skepticism and concerns about potential dilution, the community is closely watching for further movement and webinar updates.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and the FC SAN business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

AVGO is trending downwards as investors react to concerns about AI revenue translation and margin specifics revealed in the recent earnings report, sparking a sell-off. Community discussions revolve around potential support levels and whether the stock is oversold, with some traders expressing frustration over losses and perceived manipulation. Despite analyst upgrades, the stock's sharp decline has led to debates about its valuation and future prospects in the AI sector.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. TeraWulf will generate domestically produced bitcoin powered by nuclear, hydro and solar energy. The company was founded by Paul Prager and Nazar Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulf is trending as investors debate whether recent price action represents a buying opportunity or a sign of broader sector weakness, particularly in data centers and AI-related stocks. Community members are actively discussing potential catalysts, including upcoming news about new partnerships and TeraWulf's AI/HPC contracts with Google, while also weighing the impact of short positions and overall market volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Cyclerion Therapeutics shares jumped 47% in after-hours trading on Tuesday, placing it among the session’s top five U.S. gainers, after the company said it will relaunch with a focus on developing therapies for neuropsychiatric conditions.The plan is supported by a new licensing agreement with the Massachusetts Institute of Technology (MIT) covering intellectual property that will form the basis of its research programs.The company stated its lead program is for treatment-resistant depression (TRD) and is a combination of anesthetic agents with a proprietary delivery system to restore connectivity between regions of the brain. A Phase 2 proof-of-concept trial is expected to commence in 2026 with data anticipated in 2027.Cyclerion was spun out of Ironwood Pharmaceuticals in 2019. It raised $175 million in private investment to develop its soluble guanylate cyclase (sGC) stimulator programs.&nbsp;As part of its strategic shift since then, the company sold zagociguat and CY3018 to Tisento in 2023, out-licensed praliciguat in 2021, and entered into a license option agreement for olinciguat in 2024.“This relaunch represents a pivotal moment for Cyclerion Therapeutics as we refocus our efforts on advancing breakthrough neuropsychiatric treatments for patients who have limited therapeutic options today,” said Errol DeSouza, Chairperson of Cyclerion’s Board of Directors.CEO Regina Graul said the company plans to expand into additional neuropsychiatric diseases as it builds a pipeline of novel therapies.On Stocktwits, retail sentiment was ‘extremely bullish’ amid an 842% surge in 24-hour message volume. One bullish user called Cyclerion a strong candidate for a squeeze when regular trading resumes on Wednesday.&nbsp;<stembedurl>https://stocktwits.com/carldcarpatst/message/629757983</stembedurl>Another user stated that they had been accumulating shares over the past year, citing the MIT licensing deal as validation of the company’s potential and predicting a market cap of $100 million if further announcements follow.<stembedurl>https://stocktwits.com/AshleySchaeffer_BMW/message/629746974</stembedurl><a href="https://stocktwits.com/symbol/CYCN">Cyclerion Therapeutics’ stock</a> has declined 6.2% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Cyclerion Therapeutics’ stock (CYCN) has declined 6.2% so far in 2025. (Photo credit: Getty Images)

Why Did Cyclerion Therapeutics Stock Surge Nearly 50% After-Hours Today?

The biotech is relaunching as a neuropsychiatric company, anchored by an MIT licensing deal and a lead program in treatment-resistant depression.

Equity

Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of human therapeutics. Its product pipeline includes several sGC stimulators, small molecules that act synergistically with nitric oxide on sGC to boost production of cyclic guanosine monophosphate. The company was founded on September 6, 2018 and is headquartered in Cambridge, MA.

Current Price	$1.60
Prev Close	$1.51
Open	$1.51
Dividend Yield	0.00%
50-Day Moving Average	$1.83
Beta	0.37
Avg. Volume	1.11M
PE Ratio	-2.11

52-Week High	$6.25
52-Week Low	$1.28
Market Capitalization	$5.93M
EPS (Annual)	-$1.21
Price to Book	0.62
Revenue Per Employee	$2M
Enterprise Value/EBITDA	N/A

CYCN
Cyclerion Therapeutics Inc

Feed

News

Sentiment

Fundamentals

Info

Latest CYCN News

CYCNCyclerion Therapeutics Inc